1. The document discusses risk reduction strategies for cardiac patients undergoing non-cardiac surgery, including preoperative risk stratification, coronary revascularization, pharmacological therapies, anesthetic considerations, and postoperative monitoring. 2. It provides recommendations on preoperative coronary revascularization for high-risk patients, as well as perioperative use of beta-blockers, statins, alpha-2 agonists, aspirin, calcium channel blockers, and nitroglycerin to reduce cardiac risks. 3. Intraoperatively, it recommends maintaining normothermia, considers the use of volatile anesthetics, and suggests using intraoperative echocardiography for acute hemodynamic issues. Tight control of blood glucose is also addressed.